-
21
NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
Published 2025-01-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
22
Novel therapy modalities combining photodynamic therapy and liposomal cisplatin for pancreatic cancer treatments
Published 2025-03-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
23
Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
Published 2024-09-01Subjects: Get full text
Article -
24
Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
Published 2025-01-01Subjects: Get full text
Article -
25
Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells
Published 2023-09-01Subjects: “…pancreatic cancer…”
Get full text
Article -
26
A stumbling block in pancreatic cancer treatment: drug resistance signaling networks
Published 2025-01-01Subjects: “…pancreatic cancer…”
Get full text
Article -
27
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
Published 2024-12-01Subjects: “…pancreatic cancer…”
Get full text
Article -
28
The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021
Published 2025-01-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
29
RBM47 promotes cell proliferation and immune evasion by upregulating PDIA6: a novel mechanism of pancreatic cancer progression
Published 2024-12-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
30
The therapeutic potential of vitamins A, C, and D in pancreatic cancer
Published 2025-01-01Subjects: Get full text
Article -
31
Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
Published 2025-02-01Subjects: Get full text
Article -
32
Genetically predicted causal link between the plasma lipidome and pancreatic diseases: a bidirectional Mendelian randomization study
Published 2025-01-01Subjects: Get full text
Article -
33
Sarcopenia as a Prognostic Factor of Hepatotoxicity and Lower Survival Rate in Chemotherapy of Pancreatic Cancer
Published 2020-07-01Subjects: “…pancreatic cancer…”
Get full text
Article -
34
Intratumoral <i>Fusobacterium nucleatum</i> in Pancreatic Cancer: Current and Future Perspectives
Published 2024-12-01Subjects: Get full text
Article -
35
Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging
Published 2025-01-01Subjects: Get full text
Article -
36
KRASG12C‐inhibitor‐based combination therapies for pancreatic cancer: insights from drug screening
Published 2025-02-01Subjects: Get full text
Article -
37
Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044
Published 2025-01-01Subjects: “…pancreatic cancer…”
Get full text
Article -
38
Informatics strategies for early detection and risk mitigation in pancreatic cancer patients
Published 2025-02-01Subjects: “…Pancreatic cancer…”
Get full text
Article -
39
Based on the immune system: the role of the IL-2 family in pancreatic disease
Published 2025-01-01Subjects: Get full text
Article -
40
The known genetic variants of BRCA1, BRCA2 and NOD2 in pancreatitis and pancreatic cancer risk assessment
Published 2025-01-01Subjects: Get full text
Article